Cannabidiol, or CBD, is a popular natural remedy that has been gaining traction in recent years. It is purported to have many beneficial effects, but what are the claims for CBD? In this article, we'll explore the therapeutic claims made about CBD, the evidence to back them up, and the regulations that govern its sale. Our analyses showed that pain, anxiety disorders, sleep disorders and stress are the four main therapeutic claims made about CBD and account for 31%, 67%, 27%, 11%, 13%, 77% and 10%, 37% of all medical statements made on Twitter, respectively. The Federal Trade Commission (FTC) does not enforce laws that govern the permissibility of selling CBD products in interstate commerce.
However, they do regulate advertising claims about CBD products that are already in the market. Claims about the health benefits of a CBD product, as with any other product, must be backed by competent and reliable scientific evidence. The quantity and quality of these tests vary depending on the claim. In general, it states that a CBD product treats or prevents serious illnesses or disorders or provides other health benefits similar to those of medications (e.g., ex).
If the advertiser is unable to accumulate such evidence due to regulatory or financial obstacles, they should not make these types of claims. It's also OK to make claims related to the effects of CBD on general body parts and systems. For example, you can claim that CBD supports a healthy immune system or that it can be used for joint and muscle pain. Another example is that, instead of saying that CBD can treat chronic fatigue, it could be said to improve mental alertness during the day.
The standards for CBD products, such as herbal supplements, are based on manufacturers making ethical and honest claims. You can't rely on the amount of CBD that appears on labels, unless evaluated by an independent party, such as the U. S. Pharmacopoeia Convention. In addition, you can't be sure that CBD is free of contaminants such as THC, pesticides, or heavy metals.
Some CBD manufacturers have come under government scrutiny for far-fetched and indefensible claims, such as that CBD is a panacea for cancer or COVID-19, which it is not. We need more research, but CBD may prove to be a useful and relatively non-toxic option for controlling anxiety, insomnia and chronic pain. Without sufficient high-quality evidence in human studies, we can't determine effective doses, and since CBD is currently generally available as an unregulated supplement, it's difficult to know exactly what you're consuming. CBD has been announced to alleviate anxiety, depression and PTSD. It is also marketed to promote sleep.
Part of its popularity is due to the fact that it purports to be “non-psychoactive” and that consumers can get health benefits from the plant without the high (or cravings for pizza at midnight). While CBD cannot be marketed for specific health conditions, companies can make claims about how its therapeutic effects can benefit overall health and well-being. However, clinical data do not support some stated uses of CBD for Parkinson's disease, schizophrenia, cancer palliation and treatment, chronic pain and spasticity, depression, anxiety disorder, insomnia and inflammation. Cannabis products that state in their marketing materials that they are intended for use in the diagnosis, cure, mitigation, treatment or prevention of diseases must go through the FDA drug approval process for human or animal use before being legally marketed. A California case alleged that the defendant company made false claims that CBD could help alleviate the symptoms of autism and that it could treat diseases such as hepatitis, cancer and Tourette syndrome. A New York case alleges false medical claims for marijuana and violations of federal securities laws. There's a fine line between making health claims and simply conveying how CBD can support health and well-being.
This clearly demonstrates that the agency is taking a risk-based approach to compliance so it's important to know which high-risk claims to avoid. Some of the cases allege that the manufacturers' CBD products made false medical claims or were mislabeled as dietary supplements or there were false claims about the amount of CBD present in the product. The FDA and FTC have issued numerous warning letters to CBD companies for making health and illness statements. Until there is better evidence to indicate that the most common uses are safe and effective, CBD will remain a product that lacks evidence to support efficacy claims for many conditions. A complaint may not result in compliance but the combination of a complaint in a video, a non-compliant tag on social media and a testimonial complaint can increase the risk. To find out if the FDA has already sent warning letters related to a health claim search for the terms “FDA warning letter” + insert statement. It's perfectly fine to make claims about how CBD can improve a person's outward appearance without affecting the structure or function of the body. Although CBD claims to have many beneficial effects it is classified under its designation as an orphan drug by The Food and Drug Administration (FDA).
The Federal Trade Commission recently requested that a CBD company be banned from spreading false or unfounded advertisements regarding the sale of a product that supposedly treats prevents or reduces risk of COVID-19 and products that supposedly treat cancer. In conclusion there are many therapeutic claims made about CBD but they must be backed up by reliable scientific evidence before being legally marketed. The FDA has issued numerous warning letters to companies making health and illness statements so it's important to know which high-risk claims to avoid when advertising your product.